These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 10910942)

  • 1. Pure red cell aplasia due to parvovirus B19 in a patient treated with rituximab.
    Sharma VR; Fleming DR; Slone SP
    Blood; 2000 Aug; 96(3):1184-6. PubMed ID: 10910942
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Successful high-titer immunoglobulin therapy for persistent parvovirus B19 infection in a lymphoma patient treated with rituximab-combined chemotherapy.
    Isobe Y; Sugimoto K; Shiraki Y; Nishitani M; Koike K; Oshimi K
    Am J Hematol; 2004 Dec; 77(4):370-3. PubMed ID: 15558805
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Parvovirus B19 infection causing red cell aplasia in renal transplantation on tacrolimus.
    Wong TY; Chan PK; Leung CB; Szeto CC; Tam JS; Li PK
    Am J Kidney Dis; 1999 Dec; 34(6):1132-6. PubMed ID: 10585325
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pure red cell aplasia due to parvovirus following treatment with CHOP and rituximab for B-cell lymphoma.
    Song KW; Mollee P; Patterson B; Brien W; Crump M
    Br J Haematol; 2002 Oct; 119(1):125-7. PubMed ID: 12358915
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Red cell aplasia due to parvovirus b19 in a patient treated with alemtuzumab.
    Crowley B; Woodcock B
    Br J Haematol; 2002 Oct; 119(1):279-80. PubMed ID: 12358942
    [No Abstract]   [Full Text] [Related]  

  • 6. Pure red cell aplasia caused by parvovirus B19 in two patients without chronic hemolysis.
    Kaneko H; Shimura K; Nishida K; Fujiwara Y; Matsumoto Y; Kuroda J; Horiike S; Yokota S; Ohkawara Y; Taniwaki M
    J Infect Chemother; 2011 Apr; 17(2):268-71. PubMed ID: 20820839
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pure red cell aplasia due to persistent B19 parvovirus infection in patient infected with human immunodeficiency virus type 1. Recovery with alpha-interferon therapy.
    Martins A; Costa A; Oliveira MJ; Rodrigues M; Ribeiro AP; Silvestre F; Reis A
    Sangre (Barc); 1998 Feb; 43(1):67-9. PubMed ID: 9577184
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human parvovirus B19 infection induced pure red cell aplasia in liver transplant recipients.
    Zhang M; Zhong X; Zhang W; Xu J; Zhang M; Shen Y; Wang W; Zheng S
    Int J Clin Pract Suppl; 2015 May; (183):29-34. PubMed ID: 26177162
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A case of parvovirus B19-induced pure red cell aplasia in a child following heart transplant.
    Kelleher E; McMahon C; McMahon CJ
    Cardiol Young; 2015 Feb; 25(2):373-5. PubMed ID: 24555951
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immune reconstitution syndrome associated with parvovirus B19-induced pure red cell aplasia during highly active antiretroviral therapy.
    Intalapaporn P; Poovorawan Y; Suankratay C
    J Infect; 2006 Aug; 53(2):e79-82. PubMed ID: 16313965
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pure red cell aplasia due to parvovirus B19 infection in a man with HIV infection.
    de Mayolo JA; Temple JD
    South Med J; 1990 Dec; 83(12):1480-1. PubMed ID: 2174578
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pure red-cell aplasia of 10 years' duration due to persistent parvovirus B19 infection and its cure with immunoglobulin therapy.
    Kurtzman G; Frickhofen N; Kimball J; Jenkins DW; Nienhuis AW; Young NS
    N Engl J Med; 1989 Aug; 321(8):519-23. PubMed ID: 2548098
    [No Abstract]   [Full Text] [Related]  

  • 13. Pure red cell aplasia caused by Parvovirus B19 infection in solid organ transplant recipients: a case report and review of literature.
    Geetha D; Zachary JB; Baldado HM; Kronz JD; Kraus ES
    Clin Transplant; 2000 Dec; 14(6):586-91. PubMed ID: 11127313
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A case of persistent anemia in a renal transplant recipient: association with parvovirus B19 infection.
    Choi SH; Chang SP; Won JC; Lee JS; Chi HS; Yang WS; Park SK
    Scand J Infect Dis; 2002; 34(1):71-5. PubMed ID: 11874173
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Persistent B19 parvovirus infection in patients infected with human immunodeficiency virus type 1 (HIV-1): a treatable cause of anemia in AIDS.
    Frickhofen N; Abkowitz JL; Safford M; Berry JM; Antunez-de-Mayolo J; Astrow A; Cohen R; Halperin I; King L; Mintzer D
    Ann Intern Med; 1990 Dec; 113(12):926-33. PubMed ID: 2173460
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravenous immunoglobulin therapy for pure red cell aplasia related to human parvovirus b19 infection: a retrospective study of 10 patients and review of the literature.
    Crabol Y; Terrier B; Rozenberg F; Pestre V; Legendre C; Hermine O; Montagnier-Petrissans C; Guillevin L; Mouthon L;
    Clin Infect Dis; 2013 Apr; 56(7):968-77. PubMed ID: 23243178
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pure red cell aplasia due to persistent human parvovirus B19 infection in healthy adult].
    Makino S; Fukuda T; Ueda A
    Nihon Naika Gakkai Zasshi; 2001 Feb; 90(2):323-5. PubMed ID: 11307293
    [No Abstract]   [Full Text] [Related]  

  • 18. Parvovirus B19-associated transient red cell aplasia in children: the role of bone marrow examination in unusual presentations.
    Garewal G; Ahluwalia J; Das R; Marwaha RK
    Pediatr Hematol Oncol; 2004 Sep; 21(6):505-11. PubMed ID: 15552814
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Parvovirus b19 infection in HIV patient with pure red cell aplasia.
    Sanphasitvong W; Poovorawan K; Boonsuk P; Assanasen T; Na Nakorn T; Poovorawan Y
    Southeast Asian J Trop Med Public Health; 2005 Sep; 36(5):1216-20. PubMed ID: 16438148
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progressive bicytopenia due to persistent parvovirus B19 infection after immunochemotherapy with fludarabine/cyclophosphamide and rituximab for relapsed B cell lymphoma.
    Hartmann JT; Meisinger I; Kröber SM; Weisel K; Klingel K; Kanz L
    Haematologica; 2006 Dec; 91(12 Suppl):ECR49. PubMed ID: 17194655
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.